164 related articles for article (PubMed ID: 37935785)
1. Characterization of respiratory bacterial co-infection and assessment of empirical antibiotic treatment in patients with COVID-19 at hospital admission.
Antuori A; Giménez M; Linares G; Cardona PJ
Sci Rep; 2023 Nov; 13(1):19302. PubMed ID: 37935785
[TBL] [Abstract][Full Text] [Related]
2. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
[TBL] [Abstract][Full Text] [Related]
3. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
[TBL] [Abstract][Full Text] [Related]
4. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
5. Bacterial co-infections with SARS-CoV-2.
Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
[TBL] [Abstract][Full Text] [Related]
6. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
[TBL] [Abstract][Full Text] [Related]
7. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study.
López-Herrero R; Sánchez-de Prada L; Tamayo-Velasco A; Lorenzo-López M; Gómez-Pesquera E; Sánchez-Quirós B; de la Varga-Martínez O; Gómez-Sánchez E; Resino S; Tamayo E; Álvaro-Meca A
Eur J Public Health; 2023 Aug; 33(4):675-681. PubMed ID: 37087109
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
[TBL] [Abstract][Full Text] [Related]
10. Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020-2021.
Floridia M; Giuliano M; Monaco M; Palmieri L; Lo Noce C; Palamara AT; Pantosti A; Brusaferro S; Onder G;
Antimicrob Resist Infect Control; 2022 May; 11(1):74. PubMed ID: 35598032
[TBL] [Abstract][Full Text] [Related]
11. Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19.
Lee J; Chang E; Jung J; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Bae S
J Korean Med Sci; 2023 Jan; 38(4):e37. PubMed ID: 36718563
[TBL] [Abstract][Full Text] [Related]
12. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
[TBL] [Abstract][Full Text] [Related]
13. Bacterial coinfections in COVID-19: an underestimated adversary.
Fattorini L; Creti R; Palma C; Pantosti A; ;
Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
Alshaikh FS; Godman B; Sindi ON; Seaton RA; Kurdi A
PLoS One; 2022; 17(8):e0272375. PubMed ID: 35913964
[TBL] [Abstract][Full Text] [Related]
15. Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infections.
Duan Y; Wang J; Wang S; Zhang R; Hu J; Li W; Chen B
Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):577-586. PubMed ID: 38246947
[TBL] [Abstract][Full Text] [Related]
16. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
[TBL] [Abstract][Full Text] [Related]
18. Observational Study on Secondary Bacterial Infection and the Use of Antibiotics in COVID-19 Patients Treated in a Tertiary Referral Hospital.
Lie KC; Shakinah S; Pasaribu A; Sinto R; Nainggolan L
Acta Med Indones; 2022 Apr; 54(2):161-169. PubMed ID: 35818653
[TBL] [Abstract][Full Text] [Related]
19. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya.
Asmarawati TP; Rosyid AN; Suryantoro SD; Mahdi BA; Windradi C; Wulaningrum PA; Arifianto MV; Bramantono B; Triyono EA; Rusli M; Rachman BE; Marfiani E; Endraswari PD; Hadi U; Kuntaman K; Nasronudin N
F1000Res; 2021; 10():113. PubMed ID: 33868645
[No Abstract] [Full Text] [Related]
20. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
